Home / Technology / Non-invasive measurement of blood sugar from Apple supplier

Non-invasive measurement of blood sugar from Apple supplier



Non-invasive blood sugar measurement has been described as the holy grail of medical technology, and an Apple supplier has now formally announced the solution. It says that it is now entering the test phase.

The first phase will be a stand-alone bracelet, but the hope is that the technology will make it into future Apple Watch models …

Background

We previously reported on the company’s work with a new generation of health sensors.

Apple is listed as the largest client of Rockley Photonics, an electronics company that works with a system that uses similar sensors to the existing Apple Watch, but with many more options. […]

This UK electronic startup is developing a unique spectrometer-on-a-chip platform that can detect blood pressure, glucose, hydration and alcohol levels from the wrist. […]

The existing Apple Watch sensors use a mixture of infrared and visible light to measure both heart rate and oxygen saturation. Rockley is working on more sensitive versions of these sensors, which can measure other things.

Non-invasive blood glucose measurement announcement

Rockley has today officially announced the system.

Rockley Photonics, a leading global silicon photonics technology company, today unveiled its complete, full-stack, “clinic-on-the-wrist”

; digital health sensor system.

Rockley’s sensor module and associated consumer product reference design integrate hardware and application firmware to enable portable devices to monitor multiple biomarkers, including body temperature, blood pressure, hydration, alcohol, lactate and glucose trends, among others […]

The sensor does not probe invasively under the skin to analyze blood, interstitial fluids and various layers of the dermis for constituents and physical phenomena of interest. Such biomarkers have historically only been measurable by using countertop equipment.

[The tech] will be used in a number of internal human studies in the coming months.

The company says it expects first-generation versions to be available for commercial use from the first half of next year.

As we have mentioned before, there is no guarantee yet that the trials will succeed, nor that Apple will use it in Apple Watches, but it is a safe bet that this is one of Cupertino’s most important goals for the product.

FTC: We use revenue-generating auto affiliate links. More.


Check out 9to5Mac on YouTube for more Apple news:


Source link